Active Ingredient(s): Celecoxib + Tramadol Hydrochloride
FDA Approved: * October 15, 2021
Pharm Company: * ESTEVE
Category: Pain Relief

Celecoxib/tramadol sold under the brand name Seglentis, is a fixed-dose combination of the anti-inflammatory celecoxib and the opioid tramadol used for the management and treatment of pain.[1] Developed by Spanish pharmaceutical company Esteve, it was approved for medical use in the United States in October 2021.[1][2][3] References .mw-parser-output .reflist{font-size:90%;margin-bottom:0.5em;list-style-type:decimal}.mw-parser... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Seglentis Oral Tablet
NDC: 66869-564
Kowa Pharmaceuticals America, Inc.